Page 81 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology Molecular shift in FLT3 during AML course

27. Nakamura H, Inokuchi K, Yamaguchi H, Dan K. with prognosis in acute myeloid leukemia. PLoS One.
Abnormalities of p51, p53, FLT3 and N-ras genes and 2014;9(3):e89560.
their prognostic value in relapsed acute myeloid leukemia. doi: 10.1371/journal.pone.0089560
J Nippon Med Sch. 2004;71(4):270-278.
37. Nakano Y, Kiyoi H, Miyawaki S, et al. Molecular evolution
doi: 10.1272/jnms.71.270
of acute myeloid leukaemia in relapse: Unstable N-ras
28. Tiesmeier J, Müller-Tidow C, Westermann A, et al. Evolution and FLT3 genes compared with p53 gene. Br J Haematol.
of FLT3-ITD and D835 activating point mutations in 1999;104(4):659-664.
relapsing acute myeloid leukemia and response to salvage doi: 10.1046/j.1365-2141.1999.01256.x
therapy. Leuk Res. 2004;28(10):1069-1074.
38. Shih LY, Huang CF, Wu JH, et al. Internal tandem duplication
doi: 10.1016/j.leukres.2004.02.009
of FLT3 in relapsed acute myeloid leukemia: A comparative
29. Suzuki T, Kiyoi H, Ozeki K, et al. Clinical characteristics analysis of bone marrow samples from 108 adult patients at
and prognostic implications of NPM1 mutations in acute diagnosis and relapse. Blood. 2002;100(7):2387-2392.
myeloid leukemia. Blood. 2005;106(8):2854-2861.
doi: 10.1182/blood-2002-01-0195
doi: 10.1182/blood-2005-04-1733
39. Schnittger S, Schoch C, Kern W, Hiddemann W,
30. Cloos J, Goemans BF, Hess CJ, et al. Stability and prognostic Haferlach T. FLT3 length mutations as marker for
influence of FLT3 mutations in paired initial and relapsed follow-up studies in acute myeloid leukaemia. Acta
AML samples. Leukemia. 2006;20(7):1217-1220. Haematol. 2004;112(1-2):68-78.
doi: 10.1038/sj.leu.2404246 doi: 10.1159/000077561
31. Palmisano M, Grafone T, Ottaviani E, Testoni N, Baccarani M, 40. Park SH, Chi HS, Min SK, et al. Prognostic significance of
Martinelli G. NPM1 mutations are more stable than FLT3 the FLT3 ITD mutation in patients with normal-karyotype
mutations during the course of disease in patients with acute acute myeloid leukemia in relapse. Korean J Hematol.
myeloid leukemia. Haematologica. 2007;92(9):1268-1269. 2011;46(2):88-95.
doi: 10.3324/haematol.11202 doi: 10.5045/kjh.2011.46.2.88
32. Schnittger S, Kern W, Tschulik C, et al. Minimal residual 41. Abdelhamid E, Preudhomme C, Helevaut N, et al. Minimal
disease levels assessed by NPM1 mutation-specific RQ-PCR residual disease monitoring based on FLT3 internal tandem
provide important prognostic information in AML. Blood. duplication in adult acute myeloid leukemia. Leuk Res.
2009;114(11):2220-2231. 2012;36(3):316-323.
doi: 10.1182/blood-2009-03-213389 doi: 10.1016/j.leukres.2011.11.002
33. McCormick SR, McCormick MJ, Grutkoski PS, et al. 42. Bachas C, Schuurhuis GJ, Assaraf YG, et al. The role of minor
FLT3 mutations at diagnosis and relapse in acute myeloid subpopulations within the leukemic blast compartment
leukemia: Cytogenetic and pathologic correlations, of AML patients at initial diagnosis in the development of
including cuplike blast morphology. Arch Pathol Lab Med. relapse. Leukemia. 2012;26(6):1313-1320.
2010;134(8):1143-1151.
doi: 10.1038/leu.2011.383
doi: 10.5858/2009-0292-OA.1
43. Nazha A, Cortes J, Faderl S, et al. Activating internal
34. Wang ES, Sait SN, Gold D, et al. Genomic, tandem duplication mutations of the fms-like tyrosine
immunophenotypic, and NPM1/FLT3 mutational studies kinase-3 (FLT3-ITD) at complete response and relapse
on 17 patients with normal karyotype acute myeloid in patients with acute myeloid leukemia. Haematologica.
leukemia (AML) followed by aberrant karyotype AML at 2012;97(8):1242-1245.
relapse. Cancer Genet Cytogenet. 2010;202(2):101-107.
doi: 10.3324/haematol.2012.062638
doi: 10.1016/j.cancergencyto.2010.07.117
44. Gourdin TS, Zou Y, Ning Y, et al. High frequency of
35. Wakita S, Yamaguchi H, Omori I, et al. Mutations of the rare structural chromosome abnormalities at relapse of
epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at cytogenetically normal acute myeloid leukemia with FLT3
diagnosis may induce FLT3-ITD at relapse in de novo acute internal tandem duplication. Cancer Genet. 2014;207:467-473.
myeloid leukemia. Leukemia. 2013;27(5):1044-1052.
doi: 10.1016/j.cancergen.2014.10.002
doi: 10.1038/leu.2012.317
45. Shih LY, Huang CF, Wu JH, et al. Heterogeneous patterns
36. Janke H, Pastore F, Schumacher D, et al. Activating FLT3 of FLT3 Asp(835) mutations in relapsed de novo acute
mutants show distinct gain-of-function phenotypes in vitro myeloid leukemia: A comparative analysis of 120 paired
and a characteristic signaling pathway profile associated diagnostic and relapse bone marrow samples. Clin Cancer

Volume 9 Issue 3 (2025) 73 doi: 10.36922/EJMO025150101